Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused ...

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

Abelacimab is currently in Phase 3 development, with the lead indication for prevention of stroke and systemic embolism in patients ... Three Phase 3 clinical trials are ongoing for patients at risk ...

Novartis has announced its acquisition of Anthos Therapeutics, a Boston-based biopharmaceutical company focused on developing abelacimab, an inve ...

CDC data shows a 15% increase in stroke cases among younger Americans over the past decade, with significant rises in risk ...

Using hormonal birth control methods, such as "the pill," may increase users' risk of blood clots, strokes and heart attacks, ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Driven by rising rates of high blood pressure, obesity, and other key risk factors, heart disease remains the leading cause ...

UTA study finds that Americans over 65 who experienced parental divorce as children are more likely to suffer a stroke ...

Two medical researchers in China even provided a full list of foods participants reported that resulted in the lowest stroke ...

After adjusting for potential confounders (age, sex, race, use of birth control, pregnancy), findings showed propranolol use was associated with a significant reduction in the risk of stroke among ...

Aims Previous studies have suggested an association between retinal artery occlusion (RAO) and ischaemic stroke (IS), both ...